Cite
Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet Database
MLA
Scire’, C., et al. Drug Survival of the First Course of Anti-TNF Agents in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthritis: Analysis from the MonitorNet Database. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308941007&authtype=sso&custid=ns315887.
APA
Scire’, C., Caporali, R., Sarzi Puttini, P., Frediani, B., Di Franco, M., Tincani, A., Sinigaglia, L., Sfriso, P., Tirri, R., Bellis, E., Delsante, G., Porru, G., Salaffi, F., Giuggioli, D., Rossini, M., Todoerti, M., Bazzichi, L., Govoni, M., Gerli, R., … Todesco S. (2013). Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet Database.
Chicago
Scire’, C, R Caporali, P Sarzi Puttini, B Frediani, M Di Franco, A Tincani, L Sinigaglia, et al. 2013. “Drug Survival of the First Course of Anti-TNF Agents in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthritis: Analysis from the MonitorNet Database.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308941007&authtype=sso&custid=ns315887.